Applications of emerging molecular technologies in glioblastoma multiforme.

Abstract excerpt

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. Median survival from the time of diagnosis is less than a year, with less than 5% of patients surviving 5 years. These tumors are thought to arise through two different pathways. Primary GBMs represent de novo tumors, while secondary GBMs represent the malignant progression of lower-grade astrocytomas. Moreover, despite improvements...

Topics

Join the communities discussing this publication.

• Biomarkers, Tumor
• Brain Neoplasms
• Chromosome Mapping
• Glioblastoma
• Molecular Probe Techniques